Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience

Brandi Vollmer, Kavita V Nair, Stefan H Sillau, John Corboy, Timothy Vollmer, Enrique Alvarez

Open source

DOI: 10.1177/2055217317725102
Published: 2017-08-17
Container: Multiple Sclerosis Journal - Experimental, Translational and Clinical
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/2055217317725102,
  title = {Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience},
  author = {Brandi Vollmer and Kavita V Nair and Stefan H Sillau and John Corboy and Timothy Vollmer and Enrique Alvarez},
  year = {2017},
  journal = {Multiple Sclerosis Journal - Experimental, Translational and Clinical},
  doi = {10.1177/2055217317725102},
  url = {https://doi.org/10.1177/2055217317725102}
}

RIS

TY  - JOUR
TI  - Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience
AU  - Brandi Vollmer
AU  - Kavita V Nair
AU  - Stefan H Sillau
AU  - John Corboy
AU  - Timothy Vollmer
AU  - Enrique Alvarez
PY  - 2017
JO  - Multiple Sclerosis Journal - Experimental, Translational and Clinical
DO  - 10.1177/2055217317725102
UR  - https://doi.org/10.1177/2055217317725102
ER  -

APA

Vollmer, B., Nair, K. V., Sillau, S. H., Corboy, J., Vollmer, T., & Alvarez, E. (2017). Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience. Multiple Sclerosis Journal - Experimental, Translational and Clinical. https://doi.org/10.1177/2055217317725102

Source records

crossref · retrieved 2026-09-26T11:01:07.786Z